遗传性听力损失的基因疗法:更新和剩余的挑战
1Department of Human Molecular Genetics and Biochemistry, Faculty of Medicine and Sagol School of Neuroscience, Tel Aviv University, Tel Aviv 6997801, Israel.
Audiology research
|December 22, 2023
概括
基因疗法为遗传性听力损失提供了希望,这是一个日益严重的全球健康问题. 虽然在小鼠模型中是有希望的,但在人类临床应用方面仍然存在挑战.
科学领域:
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 遗传学 是一个遗传学.
- 再生医学是一种再生医学.
背景情况:
- 在全球范围内,听力损失是最常见的感官缺陷,预测到2050年,10%的人口将受到影响.
- 遗传因素约占先天性听力损失病例的一半.
- 目前的治疗方法,如助听器和耳植入物,不能完全恢复听力.
研究的目的:
- 审查遗传性听力损失的基因疗法策略.
- 总结一下最近在遗传性聋症研究中的临床前进展.
- 确定耳基因疗法的当前障碍.
主要方法:
- 对基因疗法策略的文献综述.
- 在遗传性听力损失模型中分析临床前研究结果.
- 识别和分类耳基因疗法的挑战.
主要成果:
- 基因疗法已经在小鼠模型中显示出某些形式的遗传性聋的前景.
- 在听力损失的临床前基因疗法研究中取得了重大进展.
- 在将这些发现转化为人类临床应用方面,仍然存在关键挑战.
结论:
- 基因疗法是治疗遗传性听力损失的快速发展领域.
- 克服当前的障碍对于耳基因疗法的未来临床成功至关重要.
- 需要进一步的研究来弥合临床前承诺和治疗现实之间的差距.
相关概念视频
Gene Therapy
25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K
Unrenewable Cells
2.3K
In humans, the photoreceptor cells of the eye and sensory hair cells of the ear lack stem cells. These cells are thus unrenewable and cannot be replaced when they are damaged or destroyed.
Photoreceptors
The retina is composed of several layers and contains specialized cells called photoreceptors. The photoreceptors (rods and cones) change their membrane potential when stimulated by light energy. There are two types of photoreceptors—rods and cones—which differ in the shape of...
Photoreceptors
The retina is composed of several layers and contains specialized cells called photoreceptors. The photoreceptors (rods and cones) change their membrane potential when stimulated by light energy. There are two types of photoreceptors—rods and cones—which differ in the shape of...
2.3K
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K


